XML 61 R39.htm IDEA: XBRL DOCUMENT v3.25.0.1
Stockholders' Equity (Tables)
 12 Months Ended
Jan. 31, 2025
Share-Based Payment Arrangement [Abstract]  
Schedule of Share-Based Payment Award, Stock Options, Valuation Assumptions
The fair value of each stock option grant was estimated on the date of grant using the Black-Scholes option pricing model with the following assumptions and fair value per share:
 Fiscal Year Ended January 31,
202520242023
Volatility
33 - 36
%
35 - 40
%
34 - 40
%
Estimated life5.2 years3.5 years3.5 years
Risk-free interest rate
4.3 - 4.5
%
3.6 - 4.3
%
1.7 -4.4
%
Weighted-average fair value per share of grants$114.96 $66.95 $62.10 
Summary of Share-based Compensation, Stock Options, Activity
Stock option activity for fiscal 2025 was as follows:
  Options Outstanding
 Shares
Available for
Grant
(in millions)		Outstanding
Stock
Options
(in millions)		Weighted-
Average
Exercise Price		Aggregate
Intrinsic Value (in millions)
Balance as of January 31, 202460 12 $185.77 
Increase in shares authorized:
2013 Equity Incentive Plan36 
Restricted stock activity(23)
Exercised0 (4)173.43 
Balance as of January 31, 202573 8 $198.89 $1,140 
Vested or expected to vest8 $198.10 $1,126 
Exercisable as of January 31, 20256 $187.48 $883 
Schedule of Stock Options Outstanding
The following table summarizes information about stock options outstanding as of January 31, 2025:
 Options OutstandingOptions Exercisable
Range of Exercise
Prices		Number
Outstanding
(in millions)		Weighted-
Average
Remaining
Contractual Life
(Years)		Weighted-
Average
Exercise
Price		Number of
Shares
(in millions)		Weighted-
Average
Exercise
Price
$1.34 to $154.14
2 2.6$128.18 2 $127.85 
$157.70 to $167.45
1 2.4162.50 1 162.27 
$171.43 to $215.17
2 3.4208.80 1 211.81 
$218.21
2 4.1218.21 1 218.21 
$218.63 to $342.02
1 4.6267.30 1 238.64 
8 3.5$198.89 6 $187.48 
Schedule of Restricted Stock Activity
Restricted stock activity for fiscal 2025 is as follows:
 Restricted Stock Outstanding
 Outstanding
(in millions)		Weighted Average Grant Date Fair ValueAggregate
Intrinsic
Value (in millions)
Balance as of January 31, 202428 $202.95 
Granted - restricted stock units and awards12 302.73 
Granted - performance-based stock units1 290.64 
Canceled(3)226.68 
Vested and converted to shares(12)203.70 
Balance as of January 31, 202526 $250.50 $8,796 
Expected to vest23 $7,693 
Summary of Share-based Payment Arrangement, Expensed and Capitalized, Amount
The aggregate expected stock-based compensation expense remaining to be recognized as of January 31, 2025 was as follows (in millions):
Fiscal Period:
Fiscal 2026$2,602 
Fiscal 20271,717 
Fiscal 20281,083 
Fiscal 2029182 
Total stock-based compensation expense$5,584 
Schedule Of Shares Of Common Stock Available For Future Issuance Under Stock Option Plans
The following number of shares of common stock were reserved and available for future issuance at January 31, 2025 (in millions):
Options outstanding8 
Restricted stock awards and units and performance-based stock units outstanding26 
Stock available for future grant or issuance:
2013 Equity Incentive Plan73 
2014 Inducement Plan1 
Amended and Restated 2004 Employee Stock Purchase Plan13 
121 
Summary of Repurchases Under Share Repurchase Program
The Company repurchased the following under its Share Repurchase Program (in millions, except average price per share):
202520242023
SharesAverage price per shareAmountSharesAverage price per shareAmountSharesAverage price per shareAmount
Fiscal year ended January 3130 $260.12 $7,757 36 $210.30 $7,674 28 $144.94 $4,000 
Summary of Dividends Declared
The Company announced the following dividends in the fiscal year ended January 31, 2025 (in millions, except dividend per share):
Record DatePayment DateDividend per ShareAmount
March 14, 2024April 11, 2024$0.40 $388 
July 9, 2024July 25, 2024$0.40 $388 
September 18, 2024October 8, 2024$0.40 $385 
December 18, 2024January 9, 2025$0.40 $388